Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOLIRIS for Transplant rejection: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where SOLIRIS was used for Transplant rejection.

Most Reported Side Effects for SOLIRIS

Side Effect Reports % Deaths Hosp.
Fatigue 341 14.2% 14 95
Haemoglobin decreased 254 10.6% 12 122
Transfusion 183 7.6% 8 67
Abdominal pain 141 5.9% 8 69
Unevaluable event 140 5.8% 17 129
Dyspnoea 129 5.4% 10 57
Headache 126 5.3% 3 49
Aplastic anaemia 120 5.0% 4 27
Death 118 4.9% 118 38
Platelet count decreased 106 4.4% 12 60
Haemolysis 103 4.3% 2 53
Pyrexia 103 4.3% 11 78
Haemoglobinuria 100 4.2% 5 34
Off label use 96 4.0% 26 22
Vomiting 95 4.0% 8 54

Other Indications for SOLIRIS

Paroxysmal nocturnal haemoglobinuria (1,478) Haemolytic uraemic syndrome (811) Off label use (102) Product used for unknown indication (30) Neuromyelitis optica (17) Thrombotic microangiopathy (10) Glomerulonephritis membranoproliferative (5)

Other Drugs Used for Transplant rejection

METHYLPREDNISOLONE (968) RITUXIMAB (615) TACROLIMUS (477) HUMAN IMMUNOGLOBULIN G (327) PREDNISONE (300) MYCOPHENOLATE MOFETIL (297) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (273) ECULIZUMAB (176) THYMOCYTE IMMUNE GLOBULIN NOS (173) BORTEZOMIB (145)

Related Pages

SOLIRIS Full Profile All Transplant rejection Drugs SOLIRIS Demographics SOLIRIS Timeline